Osteotech girds for rumble with dissident investors (MassDevice)
Osteotech Disputes Dissident Stockholders' Frivolous and Redundant Initiatives (Osteotech Press Release)
Unhappy Investors cite:
poor performance and 28% stock loss under CEO Sam Owusa-Akyaw
$4M loss in 2009
passed up on 2005 acquisition offer from MTF
loss a major private-label contract with Smith & Nephew...
